Activating transcription factor 4 is required for high glucose inhibits proliferation and differentiation of MC3T3-E1...

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Activating transcription factor 4 (ATF4) is known to promote bone formation.
• The specific role of ATF4 in high glucose-induced osteoblast injury remains unclear.
• Understanding these mechanisms is vital for addressing bone health in metabolic disorders.

Purpose of the Study:

• To elucidate the role of ATF4 in high glucose-induced injury of osteoblasts.
• To investigate the impact of ATF4 modulation on osteoblast viability and differentiation under high glucose conditions.
• To explore the relationship between ATF4 and endoplasmic reticulum stress markers in this context.

Main Methods:

• MC3T3-E1 cells were transfected with small interfering RNA (siRNA) or plasmids to manipulate ATF4 levels.
• Cell viability was assessed using MTT assays.
• Alkaline phosphatase (ALP) and Osteocalcin (OCN) expression, key osteogenic markers, were measured via biochemical assays, ELISA, qRT-PCR, and Western blotting.
• Levels of ATF4, GRP78, and CHOP (ER stress markers) were analyzed by PCR and Western blot.

Main Results:

• High glucose significantly inhibited MC3T3-E1 cell viability and osteogenic marker expression (ALP, OCN).
• High glucose upregulated ATF4, GRP78, and CHOP expression in these cells.
• siRNA-mediated ATF4 knockdown partially rescued cell viability and osteogenic differentiation, while ATF4 overexpression exacerbated high glucose-induced inhibition.
• ATF4 was identified as a necessary mediator for high glucose to impair osteoblast proliferation and differentiation.

Conclusions:

• ATF4 plays a critical role in mediating high glucose-induced damage to osteoblasts.
• Targeting ATF4 may offer a therapeutic strategy to protect osteoblasts from hyperglycemia-related injury.
• The findings highlight the involvement of ATF4 and ER stress pathways in diabetic bone complications.